SARAH YEAGLEY: Open Payments
NPI 1316513047 · CAPAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 14 payments from 8 companies in 2025. Trend: 2023 $103 · 2024 $322 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $79 |
| Corcept Therapeutics | 2 | $46 |
| Novo Nordisk Inc | 2 | $36 |
| Lilly USA, LLC | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Astellas Pharma US Inc | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, Korlym, Wegovy, MOUNJARO, TRELEGY ELLIPTA, CAPLYTA, Veozah, OTEZLA.
Industry payments across MI — which companies pay providers there.
